Comment on ‘Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab bevacizumab alone in women with newly diagnosed advanced ovarian cancer’. (. 2021 Sep 30;13:17588359211049639)

Autor:	Hidekatsu Nakai, Noriomi Matsumura
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Druh dokumentu:	article
ISSN:	1758-8359 17588359
DOI:	10.1177/17588359231168509
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/eec7ae4828aa47ca82bbbdfd04d48e3e Zobrazit plný text záznamu View record in DOAJ